SE395699B - Forfarande for framstellning av kinuklidin-kinolinderivat - Google Patents

Forfarande for framstellning av kinuklidin-kinolinderivat

Info

Publication number
SE395699B
SE395699B SE7103329A SE332971A SE395699B SE 395699 B SE395699 B SE 395699B SE 7103329 A SE7103329 A SE 7103329A SE 332971 A SE332971 A SE 332971A SE 395699 B SE395699 B SE 395699B
Authority
SE
Sweden
Prior art keywords
kinuklidin
kinolin
derivative
procedure
preparation
Prior art date
Application number
SE7103329A
Other languages
English (en)
Swedish (sv)
Inventor
G Grethe
M R Uskokovic
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SE395699B publication Critical patent/SE395699B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C07D453/04Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems having a quinolyl-4, a substituted quinolyl-4 or a alkylenedioxy-quinolyl-4 radical linked through only one carbon atom, attached in position 2, e.g. quinine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7103329A 1970-03-16 1971-03-15 Forfarande for framstellning av kinuklidin-kinolinderivat SE395699B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2003470A 1970-03-16 1970-03-16

Publications (1)

Publication Number Publication Date
SE395699B true SE395699B (sv) 1977-08-22

Family

ID=21796376

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7103329A SE395699B (sv) 1970-03-16 1971-03-15 Forfarande for framstellning av kinuklidin-kinolinderivat

Country Status (14)

Country Link
AT (1) AT341116B (xx)
BE (1) BE764252A (xx)
CA (1) CA940530A (xx)
CH (2) CH590274A5 (xx)
DE (1) DE2111938A1 (xx)
DK (1) DK137189B (xx)
FR (1) FR2100618B1 (xx)
GB (1) GB1313963A (xx)
IE (1) IE35284B1 (xx)
IL (1) IL36400A (xx)
NL (1) NL7103506A (xx)
PH (1) PH9976A (xx)
SE (1) SE395699B (xx)
ZA (1) ZA711588B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH605916A5 (xx) * 1973-12-07 1978-10-13 Hoffmann La Roche
FR2381044A1 (fr) * 1977-02-17 1978-09-15 Hoffmann La Roche Procede pour la preparation de mefloquine
DE2860188D1 (en) * 1977-06-15 1981-01-08 Devinter Sa Novel method for the preparation of quinidine.
US6566372B1 (en) 1999-08-27 2003-05-20 Ligand Pharmaceuticals Incorporated Bicyclic androgen and progesterone receptor modulator compounds and methods
TR200200507T2 (tr) * 1999-08-27 2002-10-21 Ligand Pharmaceuticals Inc Androjen reseptörü modülatör bileşikleri ve metotları
WO2001016133A2 (en) 1999-08-27 2001-03-08 Ligand Pharmaceuticals Incorporated 8-substituted-6-trifluoromethyl-9-pyrido[3,2-g]quinoline compounds as androgen receptor modulators
WO2001019770A2 (en) 1999-09-14 2001-03-22 Ligand Pharmaceuticals Incorporated Rxr modulators with improved pharmacologic profile

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH533123A (de) * 1968-07-02 1973-01-31 Hoffmann La Roche Verfahren zur Herstellung von Chinolinderivaten

Also Published As

Publication number Publication date
CH590274A5 (xx) 1977-07-29
IL36400A0 (en) 1971-05-26
AT341116B (de) 1978-01-25
IE35284L (en) 1971-09-16
DK137189B (da) 1978-01-30
ZA711588B (en) 1971-12-29
DE2111938A1 (de) 1971-10-07
FR2100618A1 (xx) 1972-03-24
DK137189C (xx) 1978-07-03
IE35284B1 (en) 1976-01-07
BE764252A (fr) 1971-09-15
NL7103506A (xx) 1971-09-20
GB1313963A (en) 1973-04-18
PH9976A (en) 1976-06-16
IL36400A (en) 1973-07-30
CA940530A (en) 1974-01-22
CH590275A5 (xx) 1977-07-29
ATA220971A (de) 1977-05-15
FR2100618B1 (xx) 1974-08-23

Similar Documents

Publication Publication Date Title
SE393381B (sv) Analogiforfarande for framstellning av 8-azapurin - 6 - onderivat
SE384211B (sv) Forfarande for framstellning av 2-substituerade-4-amino-6,7,8-trialkoxikinazoliner
BG19802A3 (bg) Метод за получаване на фенил-имидазолилалканилови производни
SE385885B (sv) Foerfarande foer framstaellning av 4-amino-6-arylpyrimidinderivat
SE394678B (sv) Analogiforfarande for framstellning av pyridokinolinderivat
SE384368B (sv) Forfarande for framstellning av 6-substituerade - 4 - amino- 1,2 - dihydro - 1 - hydroxi - 2 - iminopyrimidiner
NO138883C (no) Fremgangsmaate for fremstilling av oksiranforbindelser
SE397677B (sv) Forfarande for framstellning av en alfa-dipeptidlagalkylester av l-asparaginsyra
SE399701B (sv) Forfarande for framstellning av hydroxyalkyldiamin
SE394436B (sv) Forfarande for framstellning av 7-halogen-linkomyciner
SE7511680L (sv) Forfarande for framstellning av furanderivat
SE380273B (sv) Forfarande for framstellning av tiopyrimidinderivat
SE385011B (sv) Forfarande for framstellning av alfa-linkosaminider
SE395897B (sv) Forfarande for framstellning av 7beta-acylamido-3-metyl-cef-3-em-4-karbonsyror
SE395699B (sv) Forfarande for framstellning av kinuklidin-kinolinderivat
SE384685B (sv) Forfarande for framstellning av linkomycinderivat
SE389105B (sv) Forfarande for framstellning av vissa angivna ketaziner
SE408418B (sv) Forfarande for framstellning av 5-fluor-pyrimidiner
SE380528B (sv) Forfarande for framstellning av 2-klor-7-hydroxi-11-piperazinyldibensoxazepmderivat
SE380795B (sv) Forfarande for framstellning av tiokarbamider
SE411759B (sv) Forfarande for framstellning av erytromycyliminforeningar
SE382046B (sv) Forfarande for framstellning av 1-aryloxi-2-propanol
NO136409C (no) Fremgangsm}te for fremstilling av aryloksyalkyl-morfolinderivater
SE382051B (sv) Forfarande for framstellning av 3-sulfonamid-4-hydroxifenyl-2-piperidylkarbinoler
SE382057B (sv) Forfarande for framstellning av n-hydroxialkylpiperazinylderivat